An oral tricyclic STING agonist suppresses tumor growth through remodeling of the immune microenvironment
{{output}}
Stimulator of interferon genes (STING) agonists could overcome immunosuppressive microenvironment to improve cancer immunotherapy. However, it is challenging to develop oral STING agonists to achieve systemic immunity. In this study, we discovered ZSA-51 as a ... ...
